Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss patients have different microbes in hair follicles, possibly affecting hair loss.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Eating selenium-rich rice improved antioxidant activity and signs of aging in mice.

Hidradenitis suppurativa is a skin disease caused by the breakdown of the skin's natural immune barriers, especially around hair follicles.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

UV light helped human hair transplants survive in mice without broad immunosuppression.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Skin stem cells remember past inflammation, helping them respond better to future injuries and possibly aiding in treating skin issues.

Hataedock treatment improved skin health and reduced atopic dermatitis symptoms by enhancing the skin barrier and reducing inflammation.

IVIG therapy was linked to hair regrowth in two patients with hair loss, but it's not recommended due to its risks and costs.

Helminth protein helps wounds heal better by reducing scarring and promoting tissue growth.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

The document concludes that understanding hair biology is key to treating hair disorders, with gene therapy showing potential as a future treatment.

Immune activities and specific genes are important in male pattern baldness.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Hair growth phase and certain genes can speed up wound healing, while an inflammatory mediator can slow down new hair growth after a wound. Understanding these factors can improve tissue regeneration during wound healing.

The document concludes that mouse models are helpful but have limitations for skin wound healing research, and suggests using larger animals and genetically modified mice for better human application.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

The document concludes that hair is complex, with a detailed growth cycle, structure, and clinical importance, affecting various scientific and medical fields.

Targeting TGFβ can improve skin immunity in older people.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Advanced human skin models improve drug development and could replace animal testing.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.